Literature DB >> 1283144

Endoscopic palliation for inoperable malignant dysphagia: long term follow up.

V Maunoury1, J M Brunetaud, D Cochelard, B Boniface, A Cortot, J C Paris.   

Abstract

This prospective non-randomised trial of 128 selected patients with unresectable oesophageal or gastrooesophageal junction cancers aims to evaluate the initial relief of malignant obstruction by means of bipolar electrocoagulation for both circumferential and submucosal strictures of Nd:YAG laser for the other patients. A limited dilatation was performed initially if a small calibre endoscope was unable to pass through the stricture. Prompt and significant relief of dysphagia without complications was achieved in 83% of patients. Improved patients were retreated monthly during the follow up period. Radiotherapy was recommended when possible. Symptomatic relief of obstruction lasted 4.2 months on average and 76% of patients remained palliated until death. Monthly retreatment using the most appropriate endoscopic procedure for the tumour configuration and radiotherapy after endoscopic relief of obstruction seems to give the best palliation for patients with unresectable cancers of the oesophagus or gastrooesophageal junction.

Entities:  

Mesh:

Year:  1992        PMID: 1283144      PMCID: PMC1379568          DOI: 10.1136/gut.33.12.1602

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Palliation of malignant dysphagia: surgery, radiotherapy, laser, intubation alone or in combination?

Authors:  S G Bown
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

2.  Endoscopic laser palliation for advanced malignant dysphagia.

Authors:  S G Bown; R Hawes; K Matthewson; C P Swain; H Barr; P B Boulos; C G Clark
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

3.  Palliation of esophagogastric cancer via endoscopy.

Authors:  D M Jensen
Journal:  Gastroenterol Clin Biol       Date:  1987-05

4.  Evaluation of the effectiveness of through-the-scope balloons as dilators of benign and malignant gastrointestinal strictures.

Authors:  D Y Graham; N Tabibian; J T Schwartz; J L Smith
Journal:  Gastrointest Endosc       Date:  1987-12       Impact factor: 9.427

5.  Endoscopic Nd-YAG laser therapy as palliative treatment for esophageal and cardial cancer. Parameters affecting long-term outcome.

Authors:  S Naveau; A Chiesa; T Poynard; J C Chaput
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

6.  Adenocarcinoma of the stomach: current results of treatment.

Authors:  L S Bizer
Journal:  Cancer       Date:  1983-02-15       Impact factor: 6.860

7.  Development of surgery for carcinoma of the esophagus.

Authors:  H Akiyama; M Tsurumaru; G Watanabe; Y Ono; H Udagawa; M Suzuki
Journal:  Am J Surg       Date:  1984-01       Impact factor: 2.565

Review 8.  Oesophageal squamous cell carcinoma: I. A critical review of surgery.

Authors:  R Earlam; J R Cunha-Melo
Journal:  Br J Surg       Date:  1980-06       Impact factor: 6.939

9.  Comparison of low-power YAG laser and BICAP tumor probe for palliation of esophageal cancer strictures.

Authors:  D M Jensen; G Machicado; G Randall; L A Tung; S English-Zych
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

10.  Endoscopic laser therapy for malignancies affecting the esophagus and gastroesophageal junction. Analysis of technical and functional efficacy.

Authors:  M H Mellow; H Pinkas
Journal:  Arch Intern Med       Date:  1985-08
View more
  4 in total

1.  Laser and brachytherapy in the palliation of adenocarcinoma of the oesophagus and cardia.

Authors:  G M Spencer; S M Thorpe; I R Sargeant; G M Blackman; J Solano; J S Tobias; S G Bown
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

Review 2.  Management of carcinomas of the upper gastrointestinal tract.

Authors:  P Ellis; D Cunningham
Journal:  BMJ       Date:  1994-03-26

3.  Palliation of malignant dysphagia by ethanol induced tumour necrosis.

Authors:  C U Nwokolo; J J Payne-James; D B Silk; J J Misiewicz; D E Loft
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

4.  Quality of life measurement in patients with oesophageal cancer.

Authors:  J M Blazeby; M H Williams; S T Brookes; D Alderson; J R Farndon
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.